Dr. Rod Corriveau joined the NINDS as a Program Director in 2010 and is responsible for the NINDS Alzheimer’s disease and vascular dementia portfolios, as well as the NINDS Repository. He was the NIH program lead for the 2013 Alzheimer’s Disease-Related Dementias Conference, held in response to the 2012 National Plan to Address Alzheimer’s Disease, which developed prioritized research recommendations to guide research in the Alzheimer’s-related dementias for the next 5 to 10 years. Rod received his bachelor’s degree in biochemistry from Simon Fraser University, and his Ph.D. in Neurosciences from the University of California San Diego. His graduate and postdoctoral studies focused on gene expression and the role of electrical activity in neural circuit development. As an HHMI Postdoctoral Associate with Carla Shatz at UC Berkeley, he contributed to the discovery of a role for immune molecules in synaptic development and change. Dr. Corriveau was an Assistant Professor at the LSU Health Sciences Center where he investigated the role of NMDA receptor-dependent neural signaling in gene expression and naturally occurring neuronal cell death. Prior to joining NINDS, he was an Associate Professor at the Coriell Institute for Medical Research.
Last Modified July 22, 2013